Market Failure and the Poverty of New Drugs in Maternal Health

Preprint
Publisher Website
Google Scholar
  • 1 January 2008
    • preprint
      • Published in RePEc
Abstract
A new survey finds that only 17 drugs are under active development for maternal health indications, which is less than 3% of the pipeline in cardiovascular health (660 drugs). The international agencies have forgotten pregnant women. Given the unacceptably high number of maternal and perinatal deaths each year, it is high time to address this issue. [Policy Forum January 2008, Volume 5, Issue 1].
All Related Versions

This publication has 0 references indexed in Scilit: